Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

83 results about "Posterior capsule" patented technology

The posterior capsule is the clear layer of tissue that supports the intraocular lens, which is implanted into the eye at the time of cataract surgery. Over time after cataract surgery, the posterior capsule may lose its clarity.

Accommodative intraocular lens

A two-optic accommodative lens system. The first lens has a negative power and is located posteriorly within the capsular bag and laying against the posterior capsule. The periphery of the first lens contains a pair of generally T-shaped haptics oriented along a vertical meridian of the capsular bag and having a generally rectangular slot within the top portion of the “T”. The first lens further having a plurality of elongated haptics oriented along a horizontal meridian of the capsular bag. The second lens is located anteriorly to the first lens outside of the capsular bag and is of a positive power. The peripheral edge of the second lens contains a pair of encircling haptics having a notched tab sized and shape to fit within the slots in the haptics on the first lens to lock the second lens onto the first lens. Hinge structures on the encircling haptics allow the second lens to move relative to the first lens along the optical axis of the lens system in reaction to movement of the ciliary muscle.
Owner:ALCON INC

Bag-in-the-lens intraocular lens with removable optic and capsular accommodation ring

InactiveUS20070123981A1Intraocular lensOphthalmologyLens epithelial cell proliferation
This invention describes an intraocular lens (IOL) design with a removable optic, which can be inserted in and removed from a haptic device. In this haptic the anterior and posterior capsules are sealed in order to have a perfect control over the lens epithelial cell proliferation which is thereby restricted to the peripheral part of the capsular bag. Additionally, a ring caliper is described as new surgical device to allow a precise sizing and centration of the anterior capsulorhexis. The removable optic allows repeatable correction of the eye focusing over time in case the optical parameters of the eye have changed due to a variety of factors. By separating the optic part from the haptic part, the optic part can easily be manufactured in any shape matching the optical errors of the eye, including the optical aberrations. The optic part can be manufactured out of any biomaterial restoring ocular accommodation. The optic part may include prismatic, astigmatic or magnification correction to improve visual performance. The optic part may consist of or include an electronic device for the purpose of artificial vision. In order to further assist the accommodative capabilities of the implant a capsular accommodation ring of specific biomechanical properties is inserted in the capsular equator.
Owner:TASSIGNON MARIE JOSE B

Intraocular Lens Cell Migration Inhibition System

Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye.
Owner:INSIGHT INNOVATIONS

Biocompatible biodegradable intraocular implant system

Generally, an intraocular implant and methods for treating an ocular condition. As to certain embodiments, an intraocular biocompatible biodegradable implant (11) which can provide a biocompatible biodegradable material in the form of a flexible membrane (12) containing an active agent (24) which implanted between an intraocular lens (8) and the surface of the posterior capsule (5) of the eye (1)(4) inhibits migration of residual lens epithelial cells after cataract surgery by providing structural or pharmaceutical barriers to reduce posterior capsule (5) opacification of the eye (1)(4).
Owner:INSIGHT INNOVATIONS

Irrigation/Aspiration Tip

ActiveUS20080167604A1Reduce the overall diameterReduces the possibility of tearingEye surgeryCannulasBiomedical engineeringIrrigation
An irrigation / aspiration tip having a relatively rigid cannula attached to a hub and an open end opposite the hub. Coaxially and removable received over the tip is a soft elastomeric or rubber sleeve. The sleeve forms a gap between the sleeve and the cannula, the gap allowing irrigation flow. The distal end of the sleeve is closed by a cap of reduced diameter. The reduced diameter of the cap seals the distal end of the cannula. The relatively soft cap reduces the likelihood that the posterior capsule will tear during cortical clean-up and capsule polishing. Removing the sleeve allows the cannula to be resterilized an unlimited number of times, thereby allowing unlimited reuse of the cannula.
Owner:ALCON INC

Intraocular lens rings

InactiveUS20130184816A1Suitable and consistent visual acuityLong lasting fitIntraocular lensAqueous humorEquator
The invention is directed to a lens that comprises an optic and at least two haptic rings, one positioned to rest against the posterior capsule distally outward from the optic zone, the other to rest on the anterior capsule some distance from the equator. The haptic rings of the lens are connected by segments of haptic material that may be arched or straight, and sections of open space to provide for ample circulation of the aqueous humor. The optic is suspended between the two haptic rings such that the distance between the optic and the anterior ring is constant while the distance between the optic and the posterior ring may vary according to the overall capsular dimensions of the eye of the patient.
Owner:ANEW IOL TECH

Accommodating intraocular lens having T-shaped haptics

An accommodating intraocular lens having anteriorly and posteriorly movable extended portions, such as T-shaped haptics, extending from a central optic to be implanted within a natural capsular bag of a human eye with the extended portions positioned between an anterior capsular rim and a posterior capsule of the bag, whereby during a post-operative healing period, fibrosis occurs about the extended portions to fixate the lens in the bag in a manner such that subsequent natural contraction and relaxation of the ciliary muscle moves the optic to provide vision accommodation of increased accommodation amplitude and diopters of accommodation.
Owner:THE NICE TRUST

Methods and Devices for Preventing or Delaying Posterior Capsule Opacification

InactiveUS20110082543A1Prevents and minimizes and delays formationMinimize formationPharmaceutical delivery mechanismEye treatmentChemical MoietyBovine serum albumin
Several methods for preventing, minimizing, or delaying the incidence of posterior capsule opacification are provided. A first method involves chemically activating the surface of an implantable ocular device, such as an intraocular lens or a capsular tension ring, by grafting a chemical moiety onto the surface of the device, covalently attaching a non-cytotoxic inhibitor compound to the chemical moiety to produce an inhibitor implantable ocular device, and implanting this inhibitor implantable ocular device into the capsular bag of an eye of a patient during extracapsular cataract surgery. Appropriate inhibitor compounds include RGD mimetics, RGD peptides, and flavonoids. A second method involves surface modifying the exterior surface of a capsular tension ring by covalently attaching a mitotic inhibitor, preferably a conjugate of methotrexate and a bovine serum albumin, and implanting this inhibitor tension ring into the capsular bag of an eye of a patient during extracapsular cataract surgery. A third method involves surface modifying the exterior surface of a capsular tension ring by coating or grafting the exterior surface with a charged polyethylamine and implanting this inhibitor tension ring into the capsular bag of an eye of a patient during extracapsular cataract surgery. An implantable ocular device according to the invention, such as an intraocular lens or a capsular tension ring, contains a substrate with a chemical moiety grafted thereon and a non-cytotoxic inhibitor compound covalently bonded to the chemical moiety or contains a substrate modified with a mitotic inhibitor or charged polyethylamine. The inhibitor devices inhibits proliferation and migration of lens epithelial cells on the posterior capsule of the eye of the patient, thereby preventing, minimizing, or delaying the onset of posterior capsule opacification.
Owner:CLEO COSMETIC & PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products